BridgeBio Pharma Inc
BBIO
Market Cap$5.19B
Close$
$-9.02
132.6% downside
Current Fair Value
132.6% downsideOvervalued by 132.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.19 Billion |
|---|---|
| Enterprise Value | $6.48 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.95 |
| Beta | 2.06 |
| Outstanding Shares | 187,129,260 |
| Avg 30 Day Volume | 1,566,151 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.07 |
|---|---|
| PEG | -36.34 |
| Price to Sales | - |
| Price to Book Ratio | -3.46 |
| Enterprise Value to Revenue | 696.85 |
| Enterprise Value to EBIT | -10.81 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | -1.28 |
Revenue Sources
No data
ESG Score
No data
About BridgeBio Pharma Inc
CEO: Neil Kumar